Cargando…
Immunotherapy-Induced Anterior Hypophysitis
Immunotherapy-based regimens are currently the standard treatment for many different types of cancers. Monoclonal antibodies against cytotoxic T lymphocytes antigen (CTLA-4), programmed cell death protein-1 (PD-1), and PD-1 ligand (PD-L1) are the major subgroups of immune checkpoint inhibitors, whic...
Autores principales: | Pachika, Pranali S, Khanam, Razwana, Faisal, Seemal, Ahmad, Tahreem, Chandrasekhara Pillai, Anjana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8378783/ https://www.ncbi.nlm.nih.gov/pubmed/34430146 http://dx.doi.org/10.7759/cureus.16538 |
Ejemplares similares
-
Early Detection of Immune-Mediated Hypophysitis With Use of Checkpoint Inhibitor Immunotherapy
por: Yossef, Kristena, et al.
Publicado: (2022) -
A Rare Case of Ipilimumab-induced Reversible Hypophysitis and Permanent Primary Hypothyroidism
por: Erra, Amani, et al.
Publicado: (2019) -
Neurosarcoidosis-Induced Hypophysitis Mimicking Pituitary Macroadenoma
por: Ach, Taïeb, et al.
Publicado: (2023) -
Exploring a New Entity of Single-Agent Pembrolizumab-Associated Hypophysitis
por: Balti, Eric, et al.
Publicado: (2022) -
Pembrolizumab-Induced Hypophysitis With Isolated Adrenocorticotropic Hormone (ACTH) Deficiency: A Rare Immune-Mediated Adverse Event
por: Doodnauth, Andrew V, et al.
Publicado: (2021)